This trial will compare the effectiveness and safety of two types of arteriovenous access placement for people with end stage kidney disease and multiple chronic conditions.
- Kidney Failure
- Hemodialysis Complication
2 Primary · 6 Secondary · Reporting Duration: Until death, collected up to 4 years
2 Treatment Groups
graft surgically placed
1 of 2
fistula surgically placed
1 of 2
262 Total Participants · 2 Treatment Groups
Primary Treatment: fistula surgically placed · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What goals is this medical study attempting to accomplish?
"The primary aim of this clinical trial, which will last up to 4 years or until death, is to gauge the Number of Infections. Secondary outcomes include Time to successful fistula/graft access cannulation (defined as period between surgical creation and sole use for hemodialysis), Rate of adjuvant endovascular and surgical procedures (such as percutaneous thrombectomy, angioplasty with stent placement etc.), and Functional patency of study fistula or graft access (total duration in which it was used)." - Anonymous Online Contributor
How many healthcare facilities are administering this clinical experiment in the city?
"There are 8 medical centres partaking in this clinical trial. Examples include UCLA in Los Angeles, University of Alabama at Birmingham School of Medicine in Birmingham and Cleveland Clinic Glickman Urological and Kidney Institute in Cleveland. An additional 6 sites can also be found across the United States." - Anonymous Online Contributor
What is the aggregate sum of subjects participating in this experiment?
"To successfully launch this medical trial, 262 participants that meet the given criteria must be recruited. Potential enrollees can find locations in both Los Angeles and Birmingham. Specifically, UCLA in California or University of Alabama at Birmingham School of Medicine respectively." - Anonymous Online Contributor
Are there opportunities to participate in this exploration?
"Affirmative. Clinicaltrials.gov lists this clinical trial as actively accepting patients, with its initial posting on August 18th 2022 and most recent update occurring on November 11th 2022. The researchers behind the project are aiming to recruit 262 participants from 8 separate medical centres for their study." - Anonymous Online Contributor